← Back to catalogue

Microlet Next Lancing Device, Microlet Lancet

FDA 510(k)

Class II (US FDA 510(k))

510(k) K220633

by Ascensia Diabetes Care U.S., Inc.

Identifiers

510(k) Number
K220633 FDA 510(k)
FDA Product Code
QRL FDA 510(k)

Classification

Device Class
Class II FDA 510(k)
Legislation / Framework
21 CFR Part 878.4850 FDA 510(k)
Regulation Number
878.4850 FDA 510(k)
Advisory Committee
General, Plastic Surgery FDA 510(k)
FDA Decision
SESE Substantially Equivalent FDA 510(k)

The Microlet Next lancing device is a multiple use blood lancet for single patient use only, classified as a Class II medical device. It is designed for blood glucose testing and provides customizable depth settings from 1.25 mm to 2.75 mm with smooth glide technology for comfort and control during use.

The device is intended for use with Microlet silicone-coated lancets and features one-handed ejection for safe disposal. It is supplied non-sterile and is reusable by a single patient. Regulatory authorization is based on FDA 510(k) clearance (K220633) under regulation number 878.4850, with product code QRL.

Frequently asked questions

What is the Microlet Next lancing device used for?

The Microlet Next lancing device is designed for blood glucose testing, providing customizable depth settings from 1.25 mm to 2.75 mm with smooth glide technology for comfort and control during use.

Is the Microlet Next lancing device sterile or non-sterile when supplied?

The device is supplied non-sterile and is intended for reuse by a single patient only, as it is classified as a multiple use blood lancet for single patient use only.

What type of lancets are compatible with the Microlet Next lancing device?

The Microlet Next lancing device is intended for use with Microlet silicone-coated lancets and features one-handed ejection for safe disposal after use.

How is the Microlet Next lancing device regulated and authorized?

The device has FDA 510(k) clearance (K220633) under regulation number 878.4850, with product code QRL, and is classified as a Class II medical device based on substantial equivalence.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: Stechhilfe & Lanzetten | MICROLET®NEXT, MICROLET®NEXT Lancing Device | Lancet Pen | CONTOUR® - Ascensia Diabetes, The MICROLET NEXT lancing device - HCP | Ascensia Diabetes Care, Stechhilfe & Lanzetten | MICROLET®NEXT, Ascensia MICROLET NEXT Adjustable 5 Depths Lancing Device for Diabetes

Authorization Coverage (1 country)

Regulatory Authorizations

United States Active

FDA_510K

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA 510(k) K220633 24 fields · synced Oct 6, 2026